• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

产前药物暴露与致畸风险:意大利致畸信息服务中心的一年经验

Prenatal drug exposure and teratological risk: one-year experience of an Italian Teratology Information Service.

作者信息

De Santis Marco, Cesari Elena, Ligato Maria Serena, Nobili Elena, Straface Gianluca, Cavaliere Annafranca, Caruso Alessandro

机构信息

Telefono Rosso-Teratology Information Service, Department of Obstetrics and Gynecology, Catholic University of the Sacred Heart, Rome, Italy.

出版信息

Med Sci Monit. 2008 Feb;14(2):PH1-8.

PMID:18227771
Abstract

BACKGROUND

Concern about exposure to drugs, radiation, or infection during pregnancy occur often because pregnancy is not always planned. A teratology information service offers rapid scientific counseling to all those worried about prenatal exposure. The aim of this study is to present data on the most common pharmaceutical products responsible for teratogenic risk in the one-year experience of a teratology information service in Italy.

MATERIAL/METHODS: The survey was conducted among 8664 callers who contacted our Teratology Information Service in Rome between January and December 2006. Data on maternal age, gravidity, parity, maternal health status, and details of exposure (dose and timing) were collected and stored in a specific data base. Scientific counseling on prenatal exposure was given to the caller by a specialized service operator, specifying the type of risk and suggesting appropriate tests for prenatal diagnosis.

RESULTS

Most of the people called regarding drug exposure; increased risk was present in only 5% of the pregnant women calling during pregnancy. Selective serotonin reuptake inhibitors (SSRIs) are the first category that are actually considered of increased risk to the fetus. The second category is represented by antiepileptic drugs.

CONCLUSIONS

This experience confirms previous data that there is a high teratological risk perception among both women and physicians. The drugs estimated to present increased risk are medications used for chronic neurological diseases, mainly mood disorders and epilepsy. Preconceptional counseling for these women could be an effective strategy to prevent such exposure and to improve maternal and fetal outcome.

摘要

背景

由于怀孕往往并非计划之中,所以人们常常担心孕期接触药物、辐射或感染。致畸学信息服务为所有担心产前接触这些因素的人提供快速的科学咨询。本研究的目的是呈现意大利一家致畸学信息服务机构一年经验中,导致致畸风险的最常见药品的数据。

材料/方法:对2006年1月至12月期间联系罗马致畸学信息服务机构的8664名来电者进行了调查。收集了产妇年龄、妊娠次数、产次、产妇健康状况以及接触详情(剂量和时间)的数据,并存储在一个特定数据库中。由专业服务人员向来电者提供关于产前接触的科学咨询,明确风险类型并建议进行适当的产前诊断检测。

结果

大多数来电是关于药物接触;在孕期来电的孕妇中,只有5%存在风险增加的情况。选择性5-羟色胺再摄取抑制剂(SSRIs)是实际被认为对胎儿风险增加的第一类药物。第二类是以抗癫痫药物为代表。

结论

这一经验证实了先前的数据,即女性和医生对致畸风险的认知都很高。估计存在风险增加的药物是用于慢性神经疾病的药物,主要是情绪障碍和癫痫药物。对这些女性进行孕前咨询可能是预防此类接触并改善母婴结局的有效策略。

相似文献

1
Prenatal drug exposure and teratological risk: one-year experience of an Italian Teratology Information Service.产前药物暴露与致畸风险:意大利致畸信息服务中心的一年经验
Med Sci Monit. 2008 Feb;14(2):PH1-8.
2
Counselling pregnant women at the crossroads of Europe and Asia: effect of Teratology Information Service in Turkey.为处于欧亚十字路口的孕妇提供咨询:土耳其畸形学信息服务的效果
Int J Clin Pharm. 2017 Aug;39(4):783-790. doi: 10.1007/s11096-017-0496-5. Epub 2017 Jun 19.
3
Paternal exposure and counselling: experience of a Teratology Information Service.父亲暴露与咨询:一个致畸学信息服务机构的经验
Reprod Toxicol. 2008 Sep;26(1):42-6. doi: 10.1016/j.reprotox.2008.06.003. Epub 2008 Jun 12.
4
Smoke, alcohol consumption and illicit drug use in an Italian population of pregnant women.意大利孕妇人群中的吸烟、饮酒和非法药物使用情况。
Eur J Obstet Gynecol Reprod Biol. 2011 Nov;159(1):106-10. doi: 10.1016/j.ejogrb.2011.07.042. Epub 2011 Aug 9.
5
Managing fertile women under lithium treatment: the challenge of a Teratology Information Service.对接受锂治疗的育龄妇女进行管理:畸形学信息服务面临的挑战。
Minerva Ginecol. 2018 Jun;70(3):261-267. doi: 10.23736/S0026-4784.18.04190-4.
6
Czech Teratology Information Service: comparison of treatments by psychotropic and antiepileptic drugs.捷克畸形学信息服务中心:精神药物与抗癫痫药物治疗方法的比较
Neuro Endocrinol Lett. 2006 Dec;27 Suppl 2:74-7.
7
Human teratogens: update 2010.人类致畸物:2010年更新
Birth Defects Res A Clin Mol Teratol. 2011 Jan;91(1):1-7. doi: 10.1002/bdra.20748. Epub 2011 Jan 6.
8
Drugs associated with teratogenic mechanisms. Part I: dispensing rates among pregnant women in the Netherlands, 1998-2009.与致畸机制相关的药物。第一部分:1998-2009 年荷兰孕妇的配药率。
Hum Reprod. 2014 Jan;29(1):161-7. doi: 10.1093/humrep/det369. Epub 2013 Oct 8.
9
Utilisation of a NSW teratology information service by pharmacists and patients referred by a pharmacist from 2000 to 2018.2000年至2018年药剂师及由药剂师转诊的患者对新南威尔士州致畸信息服务的利用情况。
Aust N Z J Obstet Gynaecol. 2020 Jun;60(3):412-418. doi: 10.1111/ajo.13071. Epub 2019 Oct 3.
10
Cross-sectional evaluation of prescription of valproate and other antiepileptic drugs to pregnant women.横断面评估丙戊酸盐和其他抗癫痫药物在孕妇中的处方情况。
Acta Neurol Belg. 2021 Apr;121(2):503-508. doi: 10.1007/s13760-019-01231-2. Epub 2019 Oct 28.

引用本文的文献

1
Radiation exposure in pregnancy: outcomes, perceptions and teratological counseling in Turkish women.孕期辐射暴露:土耳其女性的结局、认知和致畸咨询。
Ann Saudi Med. 2022 May-Jun;42(3):214-221. doi: 10.5144/0256-4947.2022.03.03.1200. Epub 2022 Jun 2.
2
From abortion-inducing medications to Zika Virus Syndrome: 27 years experience of the First Teratogen Information Service in Latin America.从堕胎药物到寨卡病毒综合征:拉丁美洲首个致畸物信息服务机构27年的经验
Genet Mol Biol. 2019;42(1 suppl 1):297-304. doi: 10.1590/1678-4685-GMB-2018-0111. Epub 2019 Apr 11.
3
Drugs and Birth Defects: a knowledge database providing risk assessments based on national health registers.
药物与出生缺陷:基于国家健康登记系统提供风险评估的知识数据库。
Eur J Clin Pharmacol. 2013 Apr;69(4):889-99. doi: 10.1007/s00228-012-1399-y. Epub 2012 Sep 26.
4
Health care providers' requests to Teratogen Information Services on medication use during pregnancy and lactation.医疗保健提供者就孕期和哺乳期用药向致畸物信息服务机构提出的咨询。
Eur J Clin Pharmacol. 2009 May;65(5):523-31. doi: 10.1007/s00228-008-0611-6. Epub 2009 Jan 24.